Deletions of the Homeobox Gene SHOX (Short Stature Homeobox) Are an Important Cause of Growth Failure in Children with Short Stature
Gudrun A. Rappold,
Maki Fukami,
Beate Niesler,
Simone Schiller,
Walter Zumkeller,
Markus Bettendorf,
Udo Heinrich,
Elpis Vlachopapadoupoulou,
Thomas Reinehr,
Kazumichi Onigata and
Tsutomu Ogata
Institute of Human Genetics (G.A.R., M.F., B.N., S.S.) and Department of Pediatrics (M.B., U.H.), University of Heidelberg, 69120 Heidelberg, Germany; Childrens University Hospital (W.Z.), 06097 Halle, Germany; Department of Growth and Development, University of Athens (E.V.), 11527 Athens, Greece; Vestische Kinderklinik, University of Witten/Herdecke (T.R.), 45711 Datteln, Germany; Department of Pediatrics, Gunma University School of Medicine (K.O.), 371-8510 Maebashi City, Japan; and Department of Pediatrics, Keio University School of Medicine and Tokyo Electric Power Co. Hospital (T.O.), 160-0016 Tokyo, Japan
Address all correspondence and requests for reprints to: Dr. Gudrun A. Rappold, Institute of Human Genetics, University of Heidelberg, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany. E-mail: . gudrun_rappold{at}med.uni-heidelberg.de
Abstract
Short stature, with an incidence of 3 in 100, is a fairly frequentdisorder in children. Idiopathic short stature refers to patientswho are short due to various unknown reasons. Mutations of ahuman homeobox gene, SHOX (short stature homeobox), have recentlybeen shown to be associated with the short stature phenotypein patients with Turner syndrome and most patients with Léri-Weilldyschondrosteosis. This study addresses the question of theincidence and type of SHOX mutations in patients with shortstature. We analyzed the SHOX gene for intragenic mutationsby single strand conformation polymorphism, followed by sequencing,in 750 patients and for complete gene deletions by fluorescencein situ hybridization in 150 patients (total, 900 patients).This is the largest group of patients with short stature studiedto date for SHOX mutations. All patients had a normal karyotype,and their height for chronological age were below the thirdpercentile or minus 2 SD of national height standards. All werewithout obvious skeletal features reminiscent of the Leri-Weillsyndrome at the time of diagnosis.
Silent, missense, and nonsense mutations and a small deletionin the coding region of SHOX were identified in 9 of the 750patients analyzed for intragenic mutations. Complete gene deletionswere detected in 3 of the 150 patients studied for gene deletions.At least 3 of the 9 intragenic mutations were judged to be functionalbased upon the genotype- phenotype relationship for the parentsand normal control individuals. We conclude that SHOX mutationshave been detected in 2.4% of children with short stature. Thespectrum of SHOX mutations is biased, with the vast majorityleading to complete gene deletions. The prevalence of shortstature due to SHOX gene mutations among children with shortstature appears to be similar to that of GH deficiency or Turnersyndrome. Family studies of the children with SHOX mutationsoften reveal older family members with same mutation who exhibitmild skeletal features reminiscent of the Turner syndrome, suchas high-arched palate, short neck, abnormal auricular development,cubitus valgus, genu valgum, short fourth metacarpals, and Madelungdeformity.
This article has been cited by other articles:
B. C. Shah, E. S. Moran, A. R. Zinn, and J. G. Pappas Effect of Growth Hormone Therapy on Severe Short Stature and Skeletal Deformities in a Patient with Combined Turner Syndrome and Langer Mesomelic Dysplasia
J. Clin. Endocrinol. Metab.,
December 1, 2009;
94(12):
5028 - 5033.
[Abstract][Full Text][PDF]
M. R. Perkiomaki and L. Alvesalo Palatine ridges and tongue position in Turner syndrome subjects
Eur J Orthod,
April 1, 2008;
30(2):
163 - 168.
[Abstract][Full Text][PDF]
L. A. Matura, V. B. Ho, D. R. Rosing, and C. A. Bondy Aortic Dilatation and Dissection in Turner Syndrome
Circulation,
October 9, 2007;
116(15):
1663 - 1670.
[Abstract][Full Text][PDF]
G. Rappold, W. F Blum, E. P Shavrikova, B. J Crowe, R. Roeth, C. A Quigley, J. L Ross, and B. Niesler Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency
J. Med. Genet.,
May 1, 2007;
44(5):
306 - 313.
[Abstract][Full Text][PDF]
N. Sabherwal, F. Bangs, R. Roth, B. Weiss, K. Jantz, E. Tiecke, G. K. Hinkel, C. Spaich, B. P. Hauffa, H. van der Kamp, et al. Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients
Hum. Mol. Genet.,
January 15, 2007;
16(2):
210 - 222.
[Abstract][Full Text][PDF]
W. F. Blum, B. J. Crowe, C. A. Quigley, H. Jung, D. Cao, J. L. Ross, L. Braun, G. Rappold, and for the SHOX Study Group Growth Hormone Is Effective in Treatment of Short Stature Associated with Short Stature Homeobox-Containing Gene Deficiency: Two-Year Results of a Randomized, Controlled, Multicenter Trial
J. Clin. Endocrinol. Metab.,
January 1, 2007;
92(1):
219 - 228.
[Abstract][Full Text][PDF]
A. Dempfle, S. A. Wudy, K. Saar, S. Hagemann, S. Friedel, A. Scherag, L. D. Berthold, G. Alzen, L. Gortner, W. F. Blum, et al. Evidence for involvement of the vitamin D receptor gene in idiopathic short stature via a genome-wide linkage study and subsequent association studies
Hum. Mol. Genet.,
September 15, 2006;
15(18):
2772 - 2783.
[Abstract][Full Text][PDF]
C Huber, M Rosilio, A Munnich, V Cormier-Daire, and the French SHOX GeNeSIS Module High incidence of SHOX anomalies in individuals with short stature
J. Med. Genet.,
September 1, 2006;
43(9):
735 - 739.
[Abstract][Full Text][PDF]
Y-M Tan and K-Y Loke Isolated haploinsufficiency of exon 1 of the SHOX gene in a patient with idiopathic short stature.
J. Clin. Pathol.,
July 1, 2006;
59(7):
773 - 774.
[Abstract][Full Text][PDF]
S. A. DiVall and S. Radovick Deciphering the genetics of stature--another piece of the puzzle.
J. Clin. Endocrinol. Metab.,
April 1, 2006;
91(4):
1218 - 1219.
[Full Text][PDF]
G. Binder, A. Renz, A. Martinez, A. Keselman, V. Hesse, S. W. Riedl, G. Hausler, S. Fricke-Otto, H. Frisch, J. J. Heinrich, et al. SHOX Haploinsufficiency and Leri-Weill Dyschondrosteosis: Prevalence and Growth Failure in Relation to Mutation, Sex, and Degree of Wrist Deformity
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4403 - 4408.
[Abstract][Full Text][PDF]
N. Sabherwal, K. U. Schneider, R. J. Blaschke, A. Marchini, and G. Rappold Impairment of SHOX nuclear localization as a cause for Leri-Weill syndrome
J. Cell Sci.,
June 15, 2004;
117(14):
3041 - 3048.
[Abstract][Full Text][PDF]
N Sabherwal, R J Blaschke, A Marchini, D Heine-Suner, J Rosell, J Ferragut, W F Blum, and G Rappold A novel point mutation A170P in the SHOX gene defines impaired nuclear translocation as a molecular cause for Leri-Weill dyschondrosteosis and Langer dysplasia
J. Med. Genet.,
June 1, 2004;
41(6):
e83 - e83.
[Full Text][PDF]
G. Binder, M. B. Ranke, and D. D. Martin Auxology Is a Valuable Instrument for the Clinical Diagnosis of SHOX Haploinsufficiency in School-Age Children with Unexplained Short Stature
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4891 - 4896.
[Abstract][Full Text][PDF]
L Stuppia, G Calabrese, V Gatta, S Pintor, E Morizio, D Fantasia, P Guanciali Franchi, M M Rinaldi, G Scarano, D Concolino, et al. SHOX mutations detected by FISH and direct sequencing in patients with short stature
J. Med. Genet.,
February 1, 2003;
40(2):
e11 - 11.
[Full Text][PDF]
P. Saenger Growth hormone in growth hormone deficiency
BMJ,
July 13, 2002;
325(7355):
58 - 59.
[Full Text][PDF]